Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Placenta ; 54: 24-29, 2017 06.
Article in English | MEDLINE | ID: mdl-28017357

ABSTRACT

The physiological mechanisms that confer different outcomes in morbidity and mortality of the fetus exposed to stressful environments may be driven by significant differences in the expression and function of the placental glucocorticoid receptor (GR). The recent discovery that the placenta contains at least 8 different isoforms of the GR raises questions about the regulation and physiological relevance of the many GR variants expressed in the placenta. The current data also highlights that individual differences in glucocorticoid sensitivity, variations in the effect of different complications of pregnancy on birth outcomes and sex differences in the response to stress, may all be dependent on a specific GR isoform expression profile. This review will investigate the current state of knowledge of GR isoforms in the placenta and discuss the potential role of these multiple isoforms in regulating glucocorticoid sensitivity.


Subject(s)
Adaptation, Physiological , Fetal Development , Placenta/metabolism , Pregnancy Complications/metabolism , Receptors, Glucocorticoid/metabolism , Animals , Epigenesis, Genetic , Female , Humans , Pregnancy , Protein Isoforms/metabolism
2.
Allergy ; 72(3): 331-341, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27646878

ABSTRACT

Th17 cells contribute to several inflammatory conditions and increasing evidence supports that Th17 cells are glucocorticoid resistant. However, Th17 cells in psoriasis and related diseases are glucocorticoid sensitive. We compare glucocorticoid sensitive and resistant immunological diseases and suggest that several aspects in Th17-related diseases alter glucocorticoid sensitivity of Th17 cells. We identify molecular pathways that are implicated in glucocorticoid sensitivity of Th17 cells in the literature, as this information is useful for developing approaches to overcome glucocorticoid-resistant immunopathology.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Drug Tolerance , Glucocorticoids/pharmacology , Th17 Cells/drug effects , Th17 Cells/immunology , Animals , Anti-Inflammatory Agents/metabolism , Cell Differentiation/immunology , Cytokines/metabolism , Disease Susceptibility , Gene Expression Regulation , Glucocorticoids/therapeutic use , Humans , Immune System Diseases/drug therapy , Immune System Diseases/genetics , Immune System Diseases/immunology , Immune System Diseases/metabolism , Inflammation/drug therapy , Inflammation/genetics , Inflammation/immunology , Inflammation/metabolism , Signal Transduction , T-Lymphocyte Subsets/drug effects , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Th17 Cells/cytology , Th17 Cells/metabolism
3.
Allergy ; 71(5): 640-50, 2016 05.
Article in English | MEDLINE | ID: mdl-26752231

ABSTRACT

BACKGROUND: Glucocorticoid resistance has been associated with Th17-driven inflammation, the mechanisms of which are not clear. We determined whether human and mouse Th17 cells are resistant to glucocorticoid-induced apoptosis. METHODS: Freshly isolated human blood Th17 cells and in vitro differentiated Th17 cells from IL-17F red fluorescent protein reporter mice were treated with dexamethasone, a potent glucocorticoid. Apoptosis was measured using annexin V and DAPI staining. Screening of apoptosis genes was performed using the apoptosis PCR array. Levels of molecules involved in apoptosis were measured using quantitative RT-PCR, flow cytometry, and Western blotting. Knockdown of BCL-2 in murine Th17 cells was performed via retroviral transduction. Cytokines were measured using ELISA. A murine Th17-driven severe asthma model was examined for Th17 glucocorticoid sensitivity in vivo. RESULTS: Human and mouse Th17 cells and mouse Th2 cells were resistant to glucocorticoid-induced apoptosis. Th17 cells had glucocorticoid receptors levels comparable to those in other T effectors cells. Th17 cells had high levels of BCL-2, knockdown of which sensitized Th17 cells to dexamethasone-induced apoptosis. Production of IL-22, but not IL-17A and IL-17F, was suppressed by glucocorticoids. STAT3 phosphorylation in Th17 cells was insensitive to glucocorticoid inhibition. Lung Th17 cells in the murine severe asthma model were enhanced, rather than suppressed, by glucocorticoids. CONCLUSION: Th17 cells are resistant to glucocorticoid-induced apoptosis and cytokine suppression, at least in part due to high levels of BCL-2. These findings support a role of Th17 cells in glucocorticoid-resistant inflammatory conditions such as certain endotypes of asthma.


Subject(s)
Apoptosis/drug effects , Apoptosis/genetics , Genes, bcl-2 , Glucocorticoids/pharmacology , Th17 Cells/drug effects , Th17 Cells/metabolism , Animals , Asthma/genetics , Asthma/immunology , Asthma/metabolism , Asthma/pathology , Biomarkers , Cytokines/genetics , Cytokines/metabolism , Disease Models, Animal , Drug Resistance/genetics , Gene Expression , Gene Knockdown Techniques , Humans , Immunophenotyping , Lung/immunology , Lung/metabolism , Lung/pathology , Mice , T-Lymphocyte Subsets/drug effects , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Th17 Cells/immunology , Th2 Cells/drug effects , Th2 Cells/immunology , Th2 Cells/metabolism
4.
Cell Death Dis ; 4: e453, 2013 Jan 10.
Article in English | MEDLINE | ID: mdl-23303127

ABSTRACT

Induction of T-cell apoptosis contributes to the anti-inflammatory and antineoplastic benefits of glucocorticoids. The glucocorticoid receptor (GR) translational isoforms have distinct proapoptotic activities in osteosarcoma cells. Here we determined whether GR isoforms selectively induce apoptosis in Jurkat T lymphoblastic leukemia cells. Jurkat cells stably expressing individual GR isoforms were generated and treated with vehicle or dexamethasone (DEX). DEX induced apoptosis in cells expressing the GR-A, -B, or -C, but not the GR-D, isoform. cDNA microarray analyses of cells sensitive (GR-C3) and insensitive (GR-D3) to DEX revealed glucocorticoid-induced proapoptotic transcriptomes. Genes that were regulated by the proapoptotic GR-C3, but not by the GR-D3, isoform likely contributed to glucocorticoid-induced apoptosis. The identified genes include those that are directly involved in apoptosis and those that facilitate cell killing. Chromatin immunoprecipitation assays demonstrated that distinct chromatin modification abilities may underlie the distinct functions of GR isoforms. Interestingly, all GR isoforms, including the GR-D3 isoform, suppressed mitogen-stimulated cytokines. Furthermore, the GR-C isoforms were selectively upregulated in mitogen-activated primary T cells and DEX treatment induced GR-C target genes in activated T cells. Cell-specific expressions and functions of GR isoforms may help to explain the tissue- and individual-selective actions of glucocorticoids and may provide a basis for developing improved glucocorticoids.


Subject(s)
Apoptosis/drug effects , Dexamethasone/toxicity , Glucocorticoids/toxicity , Receptors, Glucocorticoid/metabolism , Transcriptome , Apoptosis Regulatory Proteins/metabolism , Bcl-2-Like Protein 11 , Chromatin/metabolism , Cytokines/metabolism , Humans , Jurkat Cells , Membrane Proteins/metabolism , MicroRNAs/metabolism , Protein Isoforms/genetics , Protein Isoforms/metabolism , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-myc/metabolism , Receptors, Glucocorticoid/genetics , T-Lymphocytes/cytology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
5.
Pharmacogenomics J ; 3(2): 114-21, 2003.
Article in English | MEDLINE | ID: mdl-12746737

ABSTRACT

Stress and sex steroidal milieu can each influence mood in women. The purpose of this study was to compare the effect of long-term conjugated equine estrogen (CEE), soy phytoestrogen (SPE), and social subordination stress on dorsal raphe serotonin neurotransmission of ovariectomized cynomolgus monkeys. Tryptophan hydroxylase (TPH) and serotonin reuptake transporter (SERT) protein content were determined, and the in vitro degradation of macaque SERT protein was examined in the presence and absence of protease inhibitors, serotonin (5-HT), and citalopram. Like CEE, SPE increased TPH protein levels. Social subordinates had markedly lower TPH protein levels than dominants regardless of hormone replacement. Therefore, these two variables had independent and additive effects. CEE and SPE increased SERT, and social status had no effect. Thus, the hormone-induced increase in SERT was accompanied by increased 5-HT synthesis and neuronal firing, which appears biologically reasonable as 5-HT prevented SERT degradation in vitro.


Subject(s)
Glycine max , Isoflavones/pharmacology , Membrane Transport Proteins , Nerve Tissue Proteins , Plant Preparations/pharmacology , Serotonin/physiology , Social Environment , Stress, Psychological/physiopathology , Synaptic Transmission/physiology , Animals , Blotting, Western , Brain Chemistry/drug effects , Carrier Proteins/metabolism , Citalopram/pharmacology , Densitometry , Dominance-Subordination , Estrogens/pharmacology , Female , Macaca fascicularis , Membrane Glycoproteins/metabolism , Mesencephalon/chemistry , Mesencephalon/metabolism , Ovariectomy , Phytoestrogens , Pineal Gland/metabolism , Protease Inhibitors/pharmacology , Serotonin/pharmacology , Serotonin Plasma Membrane Transport Proteins , Selective Serotonin Reuptake Inhibitors/pharmacology , Synaptic Transmission/drug effects , Tyrosine 3-Monooxygenase/metabolism
6.
Mol Psychiatry ; 8(3): 353-60, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12660809

ABSTRACT

The serotonin reuptake transporter (SERT) plays an important role in serotonin neurotransmission and in several psychopathological disorders such as depression and anxiety disorders. In this study, we investigated whether the ovarian steroids, estrogen (E) and progesterone (P) regulate SERT binding, intracellular distribution, and function using [(3)H]citalopram ligand binding with quantitative autoradiography, immunofluorescence histochemistry with confocal microscopy and [(3)H]serotonin uptake, respectively. Ovariectomized macaques received either placebo, E alone, P alone or E plus P for 28 days. In the raphe, E, P, and E+P treatments did not change SERT binding density. In several hypothalamic nuclei, [(3)H]citalopram binding was increased by E, P, and E+P. Immunofluorescent SERT in serotonin soma was intracellular and similar among treatments. In the hypothalamus, immunofluorescent SERT was located along the serotonergic axons and there was a significant proliferation of immunofluorescent fibers in hormone-treated animals. In addition, E and E+P treatment increased serotonin uptake in the basal ganglia. These findings suggest that ovarian hormones regulate SERT protein expression and distribution, perhaps via extracellular serotonin or mRNA stability, but not solely at the level of gene transcription. Further investigation on the possible action of ovarian steroids on the directionality of SERT transport is indicated.


Subject(s)
Carrier Proteins/metabolism , Estrogens/metabolism , Membrane Glycoproteins/metabolism , Membrane Transport Proteins , Nerve Tissue Proteins , Progesterone/metabolism , Serotonin/metabolism , Animals , Basal Ganglia/drug effects , Basal Ganglia/metabolism , Citalopram/metabolism , Citalopram/pharmacology , Depressive Disorder/metabolism , Estrogens/pharmacology , Female , Hormone Replacement Therapy , Macaca mulatta , Progesterone/pharmacology , Raphe Nuclei/drug effects , Raphe Nuclei/metabolism , Serotonin Plasma Membrane Transport Proteins , Selective Serotonin Reuptake Inhibitors/metabolism , Selective Serotonin Reuptake Inhibitors/pharmacology , Synaptosomes/drug effects , Synaptosomes/metabolism , Tritium
7.
J Dermatolog Treat ; 13(2): 67-72, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12060504

ABSTRACT

BACKGROUND: Herpes simplex facialis/labialis (HSFL) is a common infectious skin disorder, caused mainly by herpes simplex virus (HSV) type 1, for which the topical application of a cream containing an antiviral agent for treatment of the disease has been widely utilized. OBJECTIVE: To explore the efficacy of the topical application of 1% penciclovir cream in the treatment of HSFL, and to compare its efficacy and safety with 3% aciclovir cream. METHODS: A total of 248 patients with a diagnosis of HSFL were randomly allocated to one of the two treatment groups (n = 124 each), using stratified randomization based on a table of random numbers. Before treatment (day 0) and at every visit (days 3, 5 and 7) during the study, the sign and symptom scores were recorded by the same doctor. RESULTS: Excluding 23 patients (10 in the penciclovir and 13 in the aciclovir groups), 225 completed the study, and no severe adverse events were noted with any of the treatment regimens. Results show that an encouraging improvement in the clinical course was found simultaneously for patients with each episode type and each treatment assignment. There were no significant differences in terms of efficacy endpoint, clinical cure rate, and safety between the two treatment arms, but there was a trend towards a shorter time to resolution of all symptoms, cessation of new blisters, and loss of crust (p

Subject(s)
Acyclovir/analogs & derivatives , Acyclovir/administration & dosage , Antiviral Agents/administration & dosage , Facial Dermatoses/drug therapy , Herpes Labialis/drug therapy , Herpes Simplex/drug therapy , Acyclovir/adverse effects , Acyclovir/therapeutic use , Administration, Cutaneous , Adolescent , Adult , Aged , Antiviral Agents/adverse effects , Double-Blind Method , Drug Administration Schedule , Female , Guanine , Humans , Male , Middle Aged , Ointments , Pruritus/chemically induced , Treatment Outcome
8.
Brain Res Mol Brain Res ; 91(1-2): 14-22, 2001 Jul 13.
Article in English | MEDLINE | ID: mdl-11457488

ABSTRACT

This study used double in situ hybridization (ISH) to examine the colocalization of estrogen receptor beta (ERbeta) mRNA in serotonin neurons of rhesus macaques (Macaca mulatta). In addition, immunocytochemistry (ICC) was used to examine the expression and regulation of ERbeta protein in raphe neurons of the macaque midbrain. For double ISH, monkey specific riboprobes for ERbeta incorporating radiolabeled-UTP and a riboprobe for the human serotonin reuptake transporter (SERT) incorporating digoxigenin were applied to midbrain sections from spayed rhesus macaques. ERbeta mRNA hybridization signal was expressed in most cells containing SERT mRNA in the dorsal and median raphe and pons. There were also non-SERT neurons expressing ERbeta mRNA. In addition, ERbeta protein was detected with an affinity purified polyclonal antibody generated against a synthetic peptide corresponding to the D domain of human ERbeta conjugated to bovine serum albumin (provided by Dr. Philippa Saunders, MRC, Edinburgh). Midbrain sections containing the dorsal raphe from spayed rhesus macaques with and without hormone replacement therapy were processed for ERbeta immunostaining. ERbeta protein was detected at a similar intensity and in a similar number of cells in the dorsal raphe neurons in all treatment groups. Thus, the expression of ERbeta protein in the dorsal raphe was consistent with the expression of ERbeta mRNA. In conclusion, ERbeta mRNA is expressed by serotonin neurons and it is translated to protein. ERbeta protein, like ERbeta mRNA, is detected at similar levels in the presence or absence of ovarian hormones.


Subject(s)
Neurons/chemistry , Neurons/physiology , Receptors, Estrogen/analysis , Receptors, Estrogen/genetics , Serotonin/analysis , Serotonin/genetics , Affect/physiology , Animals , DNA, Complementary , Estradiol/blood , Estradiol/pharmacology , Estrogen Receptor beta , Female , Gene Expression/drug effects , Gene Expression/physiology , In Situ Hybridization , Macaca mulatta , Ovariectomy , Progesterone/blood , Progesterone/pharmacology , Protein Processing, Post-Translational , RNA, Messenger/analysis , Raphe Nuclei/cytology
9.
Int J STD AIDS ; 11(9): 568-73, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10997497

ABSTRACT

Genital herpes simplex virus (HSV) infection, a sexually transmitted disease (STD), is the commonest cause of ulcerative genital infections among the young and adult population. The significant association of genital ulceration and transmission of human immunodeficiency virus (HIV) has been shown in many studies. To explore the potential efficacy of topical treatment of genital herpes with penciclovir cream, a randomized, double-blind, multicentre, acyclovir-controlled Phase II clinical trial of penciclovir 1% cream 5 times daily up to 7 days for suppression of genital herpes was conducted in China. A total of 205 patients aged 20-59 years (mean age 36.0+/-8.8 years for acyclovir and 34.8+/-8.4 years for penciclovir) with a clinical diagnosis of genital herpes were randomly allocated to one of the 2 parallel treatment groups and used for analysis. Clinical assessment were made before treatment and followed up at every visit during the study. Our results show that there was an encouraging improvement simultaneously in the 2 groups although no significant differences in clinical efficacy with respect to clinical cure rate, and times to healing, resolution of all symptoms, absence of blisters, cessation of new blisters, crusting, and loss of crust between penciclovir and acyclovir groups in terms of primary, non-primary and total patients were found. However a significantly shorter time to crusting was found in primary penciclovir group when compared with primary acyclovir group. Adverse experience was generally infrequent and mild, and was comparable in the 2 treatment groups. Based on these preliminary clinical findings, further evaluation of penciclovir 3% cream for topical treatment of genital herpes is planned.


Subject(s)
Acyclovir/analogs & derivatives , Acyclovir/therapeutic use , Antiviral Agents/therapeutic use , Herpes Genitalis/drug therapy , Acyclovir/administration & dosage , Acyclovir/adverse effects , Administration, Topical , Adult , Antiviral Agents/administration & dosage , Antiviral Agents/adverse effects , China , Double-Blind Method , Female , Follow-Up Studies , Guanine , Humans , Male , Middle Aged , Proportional Hazards Models , Recurrence , Time Factors , Treatment Outcome
10.
J Am Acad Dermatol ; 40(2 Pt 1): 247-9, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10025753

ABSTRACT

Conventional treatments of vitiligo include topical steroids and PUVA, which necessitate prolonged application and frequent clinic visits; response to such treatments also varies. During the past few years, we have used autologous suction-blister-derived epidermal grafts in more than 150 patients with stable localized vitiligo who did not respond to topical steroids and PUVA. Up to now results are promising. In this method, spreading of the epidermal graft to its maximum size and its accurate transferral onto the recipient area are important steps. However, the graft produced by this method is so thin and soft that it wrinkles and curls frequently, making spreading and transportation to the recipient site cumbersome. In our experience with more than 700 grafts, we found that the use of plain fine gauze makes harvesting and transportation of donor grafts technically simple and effective.


Subject(s)
Skin Transplantation/instrumentation , Skin Transplantation/methods , Surgical Mesh , Vitiligo/surgery , Humans
11.
Endocrine ; 11(3): 257-67, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10786822

ABSTRACT

The effect of estrogen (E) and progesterone (P) on the protein expression of the rate-limiting enzyme in serotonin synthesis, tryptophan hydroxylase (TPH), and the level of serotonin in the hypothalamic terminal field was examined in guinea pigs. In addition, we questioned whether serotonin neurons of guinea pigs contain ovarian steroid receptors (estrogen receptoralpha[ERalpha], estrogen receptor beta[ERbeta], progestin receptors [PRs]) that could directly mediate the actions of E or P. Western blot and densitometric analysis for TPH were used on raphe extracts from untreated-ovariectomized (OVX), OVX-E-treated (28 d), and OVX-E+P-treated (14 d E+14 d E+P) guinea pigs. The medial basal hypothalami from the same animals were extracted and subjected to high-performance liquid chromatography analysis for serotonin, dopamine, 5-hydroxyindole acetic acid, and homovanillic acid. The brains from other animals treated in an identical manner were perfusion fixed and examined for the colocalization of ERalpha plus serotonin and PR plus serotonin with double immunohistochemistry or for expression of ERbeta mRNA with in situ hybridization. E and E+P treatment significantly increased TPH protein levels compared to the untreated control group (p < 0.05), but TPH levels were similar in the E and E+P-treated groups. By contrast, serotonin (nanogram/milligram of protein) in the hypothalamus was significantly increased by E+P treatment, but not by E alone. Neither ERalpha nor PR proteins were detected within serotonin neurons of the guinea pig raphe nucleus. However, ERbeta mRNA was expressed in the dorsal raphe. In summary, E alone increased TPH protein expression and the addition of P had no further effect, whereas E+P increased hypothalamic serotonin and E alone had no effect. The localization of ERbeta, but not ERalpha or PR, in the dorsal raphe nucleus suggests that E acting via ERbeta within serotonin neurons increases expression of TPH, but that P acting via other neurons and transsynaptic stimulation may effect changes in TPH enzymatic activity, which in turn, would lead to an increase in serotonin synthesis.


Subject(s)
Estrogens/pharmacology , Mesencephalon/chemistry , Progesterone/pharmacology , Receptors, Steroid/analysis , Serotonin/metabolism , Tryptophan Hydroxylase/metabolism , Animals , Biogenic Monoamines/analysis , Blotting, Western , Estrogen Receptor alpha , Estrogen Receptor beta , Estrogens/blood , Female , Guinea Pigs , Hypothalamus/chemistry , Organ Size , Ovariectomy , Pituitary Gland/anatomy & histology , Progesterone/blood , RNA, Messenger/analysis , Raphe Nuclei/chemistry , Receptors, Estrogen/analysis , Receptors, Estrogen/genetics , Receptors, Estrogen/physiology , Receptors, Progesterone/analysis , Receptors, Progesterone/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...